$5.05 Billion is the total value of Artal Group S.A.'s 94 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 50.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BUFF | Sell | BLUE BUFFALO PET PRODS INC | $2,078,070,000 | -22.6% | 87,460,875 | -23.9% | 41.14% | -25.7% |
| LXRX | LEXICON PHARMACEUTICALS INC | $1,039,349,000 | +25.9% | 57,517,977 | 0.0% | 20.58% | +20.8% | |
| GS | Buy | GOLDMAN SACHS GROUP INCcall | $443,493,000 | +138.8% | 2,750,000 | +120.0% | 8.78% | +129.0% |
| WW | WEIGHT WATCHERS INTL INC NEW | $303,855,000 | -11.3% | 29,443,300 | 0.0% | 6.02% | -14.9% | |
| BAC | BANK AMER CORPcall | $78,250,000 | +17.9% | 5,000,000 | 0.0% | 1.55% | +13.1% | |
| CELG | Buy | CELGENE CORPcall | $73,171,000 | +270.9% | 700,000 | +250.0% | 1.45% | +256.0% |
| INCY | Sell | INCYTE CORP | $56,574,000 | +13.2% | 600,000 | -4.0% | 1.12% | +8.5% |
| BIIB | BIOGEN INCcall | $46,955,000 | +29.4% | 150,000 | 0.0% | 0.93% | +24.2% | |
| BMY | New | BRISTOL MYERS SQUIBB COcall | $43,136,000 | – | 800,000 | +100.0% | 0.85% | – |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $40,668,000 | +3.2% | 600,000 | -15.5% | 0.80% | -1.0% |
| REGN | Sell | REGENERON PHARMACEUTICALScall | $40,202,000 | -4.1% | 100,000 | -16.7% | 0.80% | -8.0% |
| FXI | New | ISHARES TRcall | $38,010,000 | – | 1,000,000 | +100.0% | 0.75% | – |
| WMT | WAL-MART STORES INCcall | $36,060,000 | -1.2% | 500,000 | 0.0% | 0.71% | -5.3% | |
| MET | Buy | METLIFE INCcall | $33,323,000 | +67.3% | 750,000 | +50.0% | 0.66% | +60.6% |
| GS | GOLDMAN SACHS GROUP INC | $32,254,000 | +8.5% | 200,000 | 0.0% | 0.64% | +4.2% | |
| GOOGL | ALPHABET INCcall | $32,162,000 | +14.3% | 40,000 | 0.0% | 0.64% | +9.6% | |
| CMG | New | CHIPOTLE MEXICAN GRILL INCcall | $31,763,000 | – | 75,000 | +100.0% | 0.63% | – |
| BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $31,737,000 | -0.2% | 300,000 | -25.0% | 0.63% | -4.4% |
| ALXN | New | ALEXION PHARMACEUTICALS INCcall | $30,635,000 | – | 250,000 | +100.0% | 0.61% | – |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $27,756,000 | +1.9% | 300,000 | -14.3% | 0.55% | -2.1% |
| AGIO | New | AGIOS PHARMACEUTICALS INCcall | $26,410,000 | – | 500,000 | +100.0% | 0.52% | – |
| BLUE | Sell | BLUEBIRD BIO INC | $26,095,000 | +34.0% | 385,000 | -14.4% | 0.52% | +28.6% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $23,625,000 | +71.5% | 3,500,000 | -9.6% | 0.47% | +64.8% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $21,128,000 | +34.5% | 400,000 | +6.7% | 0.42% | +29.0% |
| KITE | Sell | KITE PHARMA INC | $17,596,000 | +8.3% | 315,000 | -3.1% | 0.35% | +3.9% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $17,180,000 | -13.8% | 1,000,000 | -28.6% | 0.34% | -17.3% |
| PFE | New | PFIZER INCcall | $16,935,000 | – | 500,000 | +100.0% | 0.34% | – |
| JPM | JPMORGAN CHASE & COcall | $16,648,000 | +7.2% | 250,000 | 0.0% | 0.33% | +2.8% | |
| IBM | INTERNATIONAL BUSINESS MACHScall | $15,885,000 | +4.7% | 100,000 | 0.0% | 0.32% | +0.6% | |
| BAC | Sell | BANK AMER CORP | $15,650,000 | +7.2% | 1,000,000 | -9.1% | 0.31% | +3.0% |
| WFC | New | WELLS FARGO & CO NEWcall | $15,498,000 | – | 350,000 | +100.0% | 0.31% | – |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $14,060,000 | +106.0% | 1,900,000 | +52.0% | 0.28% | +97.2% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $12,282,000 | – | 200,000 | +100.0% | 0.24% | – |
| MS | Sell | MORGAN STANLEY | $11,221,000 | +8.0% | 350,000 | -12.5% | 0.22% | +3.3% |
| 3106PS | Sell | DELPHI AUTOMOTIVE PLC | $10,698,000 | -37.9% | 150,000 | -45.5% | 0.21% | -40.3% |
| TSLA | Sell | TESLA MTRS INC | $10,202,000 | -35.9% | 50,000 | -33.3% | 0.20% | -38.6% |
| INCY | New | INCYTE CORPcall | $9,429,000 | – | 100,000 | +100.0% | 0.19% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $9,210,000 | – | 200,000 | +100.0% | 0.18% | – |
| AVXS | Buy | AVEXIS INC | $8,242,000 | +33.9% | 200,000 | +23.5% | 0.16% | +28.3% |
| MET | Sell | METLIFE INC | $7,775,000 | -21.9% | 175,000 | -30.0% | 0.15% | -25.2% |
| AMAG | New | AMAG PHARMACEUTICALS INC | $7,353,000 | – | 300,000 | +100.0% | 0.15% | – |
| IONS | New | IONIS PHARMACEUTICALS INCcall | $7,328,000 | – | 200,000 | +100.0% | 0.14% | – |
| CCXI | Buy | CHEMOCENTRYX INC | $7,248,000 | +79.4% | 1,200,000 | +33.3% | 0.14% | +73.5% |
| AGEN | AGENUS INC | $7,180,000 | +77.3% | 1,000,000 | 0.0% | 0.14% | +69.0% | |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INCcall | $6,778,000 | -59.3% | 100,000 | -66.7% | 0.13% | -61.0% |
| JD | JD COM INCcall | $6,523,000 | +22.9% | 250,000 | 0.0% | 0.13% | +17.3% | |
| HZNP | HORIZON PHARMA PLC | $6,346,000 | +10.1% | 350,000 | 0.0% | 0.13% | +5.9% | |
| XLRN | Buy | ACCELERON PHARMA INC | $6,333,000 | +86.4% | 175,000 | +75.0% | 0.12% | +78.6% |
| MCRB | Buy | SERES THERAPEUTICS INC | $6,145,000 | -31.8% | 500,000 | +61.3% | 0.12% | -34.4% |
| SRPT | SAREPTA THERAPEUTICS INCcall | $6,141,000 | +222.0% | 100,000 | 0.0% | 0.12% | +212.8% | |
| JUNO | JUNO THERAPEUTICS INC | $6,002,000 | -21.9% | 200,000 | 0.0% | 0.12% | -25.2% | |
| RXDX | Buy | IGNYTA INC | $5,347,000 | +31.5% | 850,000 | +13.3% | 0.11% | +26.2% |
| USFD | Sell | US FOODS HLDG CORP | $5,312,000 | -56.2% | 225,000 | -55.0% | 0.10% | -58.0% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $5,064,000 | +17.3% | 100,000 | +5.3% | 0.10% | +12.4% |
| SPNC | Sell | SPECTRANETICS CORP | $5,018,000 | -23.4% | 200,000 | -42.9% | 0.10% | -26.7% |
| BTX | BIOTIME INC | $5,000,000 | +49.4% | 1,282,050 | 0.0% | 0.10% | +43.5% | |
| NTB | New | BANK OF NT BUTTERFIELD&SON L | $4,952,000 | – | 200,000 | +100.0% | 0.10% | – |
| CEMP | Buy | CEMPRA INC | $4,840,000 | +193.5% | 200,000 | +100.0% | 0.10% | +182.4% |
| ATRA | New | ATARA BIOTHERAPEUTICS INC | $4,813,000 | – | 225,000 | +100.0% | 0.10% | – |
| FOLD | New | AMICUS THERAPEUTICS INCcall | $4,810,000 | – | 650,000 | +100.0% | 0.10% | – |
| CTRP | New | CTRIP COM INTL LTD | $4,657,000 | – | 100,000 | +100.0% | 0.09% | – |
| MGNX | New | MACROGENICS INC | $4,487,000 | – | 150,000 | +100.0% | 0.09% | – |
| ELF | New | E L F BEAUTY INC | $4,218,000 | – | 150,000 | +100.0% | 0.08% | – |
| RGNX | Buy | REGENXBIO INC | $4,203,000 | +162.7% | 300,000 | +50.0% | 0.08% | +151.5% |
| CLLS | Sell | CELLECTIS S Asponsored ads | $3,612,000 | -35.3% | 150,000 | -28.6% | 0.07% | -37.4% |
| AGEN | AGENUS INCcall | $3,590,000 | +77.3% | 500,000 | 0.0% | 0.07% | +69.0% | |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $3,547,000 | -3.3% | 50,000 | -33.3% | 0.07% | -7.9% |
| VVV | New | VALVOLINE INC | $3,524,000 | – | 150,000 | +100.0% | 0.07% | – |
| RARE | New | ULTRAGENYX PHARMACEUTICAL INcall | $3,547,000 | – | 50,000 | +100.0% | 0.07% | – |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $3,489,000 | -27.4% | 205,000 | -8.9% | 0.07% | -30.3% |
| AXGT | New | AXOVANT SCIENCES LTD | $3,500,000 | – | 250,000 | +100.0% | 0.07% | – |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $3,444,000 | +21.4% | 216,879 | 0.0% | 0.07% | +15.3% | |
| BLUE | Sell | BLUEBIRD BIO INCcall | $3,389,000 | -21.7% | 50,000 | -50.0% | 0.07% | -24.7% |
| JUNO | Buy | JUNO THERAPEUTICS INCcall | $3,001,000 | +56.1% | 100,000 | +100.0% | 0.06% | +47.5% |
| AEGR | AEGERION PHARMACEUTICALS INC | $2,970,000 | +99.3% | 1,000,000 | 0.0% | 0.06% | +90.3% | |
| ONCE | SPARK THERAPEUTICS INC | $3,003,000 | +17.4% | 50,000 | 0.0% | 0.06% | +11.3% | |
| NERV | New | MINERVA NEUROSCIENCES INC | $2,823,000 | – | 200,000 | +100.0% | 0.06% | – |
| CMRX | New | CHIMERIX INC | $2,770,000 | – | 500,000 | +100.0% | 0.06% | – |
| CLDX | CELLDEX THERAPEUTICS INC NEW | $2,727,000 | -8.0% | 675,000 | 0.0% | 0.05% | -11.5% | |
| RDUS | Sell | RADIUS HEALTH INC | $2,705,000 | -26.4% | 50,000 | -50.0% | 0.05% | -28.9% |
| ACIU | New | AC IMMUNE SA | $2,471,000 | – | 150,000 | +100.0% | 0.05% | – |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $2,305,000 | +11.1% | 100,000 | -20.0% | 0.05% | +7.0% |
| CLCD | Buy | COLUCID PHARMACEUTICALS INC | $2,121,000 | +4510.9% | 55,575 | +896.9% | 0.04% | +4100.0% |
| LOXO | New | LOXO ONCOLOGY INC | $1,964,000 | – | 75,000 | +100.0% | 0.04% | – |
| DMTX | Sell | DIMENSION THERAPEUTICS INC | $1,874,000 | +13.6% | 234,493 | -14.7% | 0.04% | +8.8% |
| DOFSQ | New | DIAMOND OFFSHORE DRILLING IN | $1,761,000 | – | 100,000 | +100.0% | 0.04% | – |
| NK | NANTKWEST INC | $1,751,000 | +25.1% | 225,000 | 0.0% | 0.04% | +20.7% | |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $1,410,000 | – | 200,000 | +100.0% | 0.03% | – |
| OPHT | Sell | OPHTHOTECH CORP | $1,384,000 | -45.8% | 30,000 | -40.0% | 0.03% | -49.1% |
| ADRO | New | ADURO BIOTECH INC | $1,243,000 | – | 100,000 | +100.0% | 0.02% | – |
| NVAX | New | NOVAVAX INC | $1,040,000 | – | 500,000 | +100.0% | 0.02% | – |
| OCX | ONCOCYTE CORPORATION | $323,000 | +41.7% | 64,102 | 0.0% | 0.01% | +20.0% | |
| CERE | Exit | CERES INC | $0 | – | -1,024,020 | -100.0% | -0.01% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -0.06% | – |
| RDUS | Exit | RADIUS HEALTH INCcall | $0 | – | -100,000 | -100.0% | -0.08% | – |
| C | Exit | CITIGROUP INC | $0 | – | -250,000 | -100.0% | -0.22% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -150,000 | -100.0% | -0.27% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -50,000 | -100.0% | -0.36% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.